Today’s Solutions: April 20, 2026

The most advanced drugs for HIV available today stop the virus from replicating, which prevents patients from developing AIDS. With that said, there is no actual cure for HIV.

Now, a team of scientists has managed to clear HIV from infected mice using the CRISPR gene-editing technology in what may be the first time the virus has been eliminated from the genomes of living animals.

The virus is currently treated with antiretroviral therapy (ART), which can suppress HIV replication but can’t eliminate every trace of the disease. The new study used both ART and CRISPR gene-editing technology, managing to destroy the virus. The researchers said they used the two treatments concurrently. First, they administered the LASER ART to reduce HIV growth, then they used the CRISPR treatment as “chemical scissors” to “eliminate the residual integrated HIV DNA still present,”.

While there is still much work needed before scientists come up with a cure suitable for humans, the findings offer a glimpse into how it might actually be done.

Solutions News Source Print this article
More of Today's Solutions

4 tips for everyday eco-friendly living

In the face of climate change, many people question the importance of individual actions in ensuring a sustainable future. While institutional change is necessary, ...

Read More

Cambodia honors the rat who cleared more landmines than anyone

BY THE OPTIMIST DAILY EDITORIAL TEAM Decades after the conflicts that planted them, landmines remain one of the most persistent threats to civilian life ...

Read More

Say goodbye to swampy feet: 6 effective ways to keep your feet dry this summer

BY THE OPTIMIST DAILY EDITORIAL STAFF Do you suffer from sweaty feet? Don't fear, you're not alone. Sweaty feet are a typical problem, particularly ...

Read More

Helping young people of color navigate the music industry with Carnegie Hall&...

BY THE OPTIMIST DAILY EDITORIAL TEAM In the iconic setting of Carnegie Hall, a remarkable initiative is taking shape, one that seeks to bridge ...

Read More